MLYS – mineralys therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Mineralys Therapeutics Announces Q3 2024 Results and Updates [Yahoo! Finance]
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Mineralys Therapeutics to Participate in Upcoming Investor Conferences
Form SC 13G/A Mineralys Therapeutics, Filed by: TCG Crossover GP II, LLC
Form SC 13G/A Mineralys Therapeutics, Filed by: HBM Healthcare Investments (Cayman) Ltd.
Form SC 13G/A Mineralys Therapeutics, Filed by: Catalys Pacific Fund, LP
Form 4 Mineralys Therapeutics, For: Nov 11 Filed by: Rodman David Malcom
Form S-8 Mineralys Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.